| Title | Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection. |
| Publication Type | Journal Article |
| Year of Publication | 2016 |
| Authors | Tetrault, Jeanette M., Janet P. Tate, Jennifer E. Edelman, Adam J. Gordon, Vincent Lo Re, Joseph K. Lim, David Rimland, Joseph Goulet, Stephen Crystal, Julie R. Gaither, Cynthia L. Gibert, Maria C. Rodriguez-Barradas, Lynn E. Fiellin, Kendall Bryant, Amy C. Justice, and David A. Fiellin |
| Journal | Journal of substance abuse treatment |
| Volume | 68 |
| Pagination | 62-7 |
| Date Published | 2016 Sep |
| ISSN | 1873-6483 |
| Abstract | Individuals with HIV and hepatitis C (HCV) infection, alcohol use disorder, or who are prescribed potentially hepatotoxic medications may be at increased risk for buprenorphine (BUP) associated hepatotoxicity. |
| DOI | 10.1016/j.jsat.2016.06.002 |
| Alternate Journal | J Subst Abuse Treat |
